Officials said the new labels must indicate the medications should not be used in children under 6 years old. The products affected are those containing any active ingredients that are given orally:
--Antihistamines: brompheniramine maleate, chlorpheniramine maleate, clemastine hydrogen fumerate, dexbrompheniramine maleate, diphenhydramine hydrochloride, doxylamine succinate, pheniramine maleate, phenyltoloxamine citrate, promethazine hydrochloride, pyrilamine maleate and triprolidine hydrochloride.
--Antitussives: dextromethorphan, dextromethorphan hydrobromide or diphenhydramine hydrochloride.
--Expectorants: guaifenesin (glyceryl guaiacolate).
--Decongestants: ephedrine hydrochloride/sulphate, phenylephrine hydrochloride/sulphate or pseudoephedrine hydrochloride/sulphate.
Health Canada said the relabeling of the medications will be completed by next fall.